SCHEMBL257705

SCHEMBL257705

CNNc1ccc(Cl)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
GAA P10253 3/20 0.44
TP53 P04637 1/20 0.44
ALDH1A1 P00352 4/20 0.44
MAPT P10636 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
HPGD P15428 2/20 0.43
TSHR P16473 1/20 0.43
MCL1 Q07820 1/20 0.43
CA1 P00915 1/20 0.43
CA14 Q9ULX7 1/20 0.43
P2RX7 Q99572 1/20 0.41
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41
PDK4 Q16654 1/20 0.41
USP2 O75604 1/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13619206 0.82 RAPGEF4 (0.48) GAATP53ALDH1A1MAPTTDP1
SCHEMBL989608 0.81 ALDH1A1 (0.52) LMNASMN1; SMN2GAATP53ALDH1A1
SCHEMBL19823741 0.80 ALDH1A1 (0.50) SMN1; SMN2GAAALDH1A1MAPTTDP1
SCHEMBL9912389 0.80 RAB9A (0.45) LMNASMN1; SMN2GAAALDH1A1MAPT
SCHEMBL6338340 0.79 TSHR (0.48) LMNASMN1; SMN2GAATP53ALDH1A1
SCHEMBL13362224 0.78 KMT2A (0.45) LMNASMN1; SMN2GAAALDH1A1MAPT
SCHEMBL14504209 0.77 TSHR (0.47) LMNASMN1; SMN2GAATP53ALDH1A1
SCHEMBL9082349 0.77 TP53 (0.50) LMNASMN1; SMN2GAATP53ALDH1A1
SCHEMBL28172323 0.76 TP53 (0.48) LMNASMN1; SMN2GAATP53ALDH1A1
SCHEMBL10439752 0.76 ALDH1A1 (0.65) LMNAGAATP53ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11655238-B2 MMPL3 inhibitors, compositions and uses thereof SHANGHAITECH UNIVERSITY (CN) 2023-05-23 US disclosed
US-20220017492-A1 MMPL3 INHIBITORS, COMPOSITIONS AND USES THEREOF SHANGHAITECH UNIVERSITY (CN) 2022-01-20 US disclosed
EP-1937259-B1 HEXAHYDRO-CYCLOHEPTAPYRAZOLE CANNABINOID MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2011-11-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655238-B2 MMPL3 inhibitors, compositions and uses thereof TIMP3, AFG3L2, MMP3 LMNA 762/4885SMN1; SMN2 4573/4885GAA 522/4885
US-20220017492-A1 MMPL3 INHIBITORS, COMPOSITIONS AND USES THEREOF TIMP3, AFG3L2, MMP3 LMNA 762/4885SMN1; SMN2 4573/4885GAA 522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.